The disease course of neuropathy due to IgM-MGUS with or without antibodies against MAG is highly variable [25] and studies assessing the efficacy of intravenous immunoglobulins [26, 27] and Rituximab [28, 29] showed inconsistent results. The gene discussed is CD40LG; the disease is neuropathy.